Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 7771 AL 7785

How can neuroimaging help in the diagnosis of movement disorders?

Ling H, Lees AJ.

Neuroimaging Clin N Am. 2010 Feb;20(1):111-23. doi: 10.1016/j.nic.2009.08.004.

Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease

Kanthasamy A, Jin H, Mehrotra S, Mishra R, Kanthasamy A, Rana A.

Neurotoxicology. 2010 Sep;31(5):555-61. doi: 10.1016/j.neuro.2009.12.003. Epub 2009 Dec 11.

The role of DAT-SPECT in movement disorders

Kägi G, Bhatia KP, Tolosa E.

J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):5-12. doi: 10.1136/jnnp.2008.157370.

Study of the prevalence of Parkinson's disease using dopamine transporter imaging

Kim JM, Kim JS, Kim KW, Lee SB, Park JH, Lee JJ, Kim YK, Kim SE, Jeon BS.

Neurol Res. 2010 Oct;32(8):845-51. doi: 10.1179/016164109X12581096796396. Epub 2009 Dec 21.

SPECT and PET in Atypical Parkinsonism

Seibyl JP.

PET Clin. 2010 Jan;5(1):65-74. doi: 10.1016/j.cpet.2010.02.005. Epub 2010 May 27.

(18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons

Hefti FF, Kung HF, Kilbourn MR, Carpenter AP, Clark CM, Skovronsky DM.

PET Clin. 2010 Jan;5(1):75-82. doi: 10.1016/j.cpet.2010.02.001. Epub 2010 May 27.

Neurotransmission in Parkinson's disease: beyond dopamine

Barone P.

Eur J Neurol. 2010 Mar;17(3):364-76. doi: 10.1111/j.1468-1331.2009.02900.x. Epub 2009 Dec 30.

Complications and side effects of deep brain stimulation in the posterior subthalamic area

Fytagoridis A, Blomstedt P.

Stereotact Funct Neurosurg. 2010;88(2):88-93. doi: 10.1159/000271824. Epub 2010 Jan 5.

Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research

Knol W, Keijsers CJ, Jansen PA, van Marum RJ.

J Clin Psychopharmacol. 2010 Feb;30(1):57-63. doi: 10.1097/JCP.0b013e3181c914b3.

Treadmill training for patients with Parkinson's disease

Mehrholz J, Friis R, Kugler J, Twork S, Storch A, Pohl M.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007830. doi: 10.1002/14651858.CD007830.pub2.

Sleep disturbances in Parkinson disease and their potential role in heterogeneity

Gunn DG, Naismith SL, Lewis SJ.

J Geriatr Psychiatry Neurol. 2010 Jun;23(2):131-7. doi: 10.1177/0891988709358591. Epub 2010 Jan 25.

C. elegans as a model organism to investigate molecular pathways involved with Parkinson's disease

Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA.

Dev Dyn. 2010 May;239(5):1282-95. doi: 10.1002/dvdy.22231.

[Experience with 123I-Iodobenzamide in the differential diagnosis of Parkinson's disease and Parkinson-plus disease]

Paniagua Correa C, García Alonso P, Balsa Bretón MA, Mariana Monguía A, Penín González FJ, Pey Illera C.

Rev Esp Med Nucl. 2010 Mar-Apr;29(2):57-62. doi: 10.1016/j.remn.2009.12.008. Epub 2010 Feb 4.

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

Louis ED, Ferreira JJ.

Mov Disord. 2010 Apr 15;25(5):534-41. doi: 10.1002/mds.22838.

Novel CDNF/MANF family of neurotrophic factors

Lindholm P, Saarma M.

Dev Neurobiol. 2010 Apr;70(5):360-71. doi: 10.1002/dneu.20760.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias